1. Home
  2. WNW vs TXMD Comparison

WNW vs TXMD Comparison

Compare WNW & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Meiwu Technology Company Limited

WNW

Meiwu Technology Company Limited

HOLD

Current Price

$1.78

Market Cap

25.8M

ML Signal

HOLD

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

HOLD

Current Price

$2.17

Market Cap

25.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WNW
TXMD
Founded
2015
2008
Country
China
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.8M
25.9M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
WNW
TXMD
Price
$1.78
$2.17
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
32.2K
168.3K
Earning Date
05-12-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.29
0.03
Revenue
$2,550,178.00
$2,796,000.00
Revenue This Year
N/A
$427.09
Revenue Next Year
N/A
N/A
P/E Ratio
$1.32
$82.02
Revenue Growth
570.49
75.19
52 Week Low
$0.95
$0.72
52 Week High
$6.66
$2.95

Technical Indicators

Market Signals
Indicator
WNW
TXMD
Relative Strength Index (RSI) 63.30 50.99
Support Level $1.40 $2.36
Resistance Level $1.56 $2.95
Average True Range (ATR) 0.14 0.26
MACD 0.02 0.00
Stochastic Oscillator 84.64 21.78

Price Performance

Historical Comparison
WNW
TXMD

About WNW Meiwu Technology Company Limited

Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Share on Social Networks: